Down Syndrome (DS) Recruiting Phase 3 Trials for Blinatumomab (DB09052)
Also known as: Downs Syndrome / Down's Syndrome / Trisomy 21 / Down Syndrome / Trisomy 21 (morphologic abnormality) / Trisomy 21 NOS / (Down's syndrome - trisomy 21) or (mongolism) or (trisomy 21) or (trisomy 22) / Syndrome Down's / Mongolism / Down's syndrome NOS (disorder) / Down's syndrome NOS / Complete trisomy 21 syndrome (disorder)
Indication | Status | Phase |
---|---|---|
DBCOND0061020 (Down Syndrome (DS)) | Recruiting | 3 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT03914625 | A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia | Treatment |
|